Industry & Hardware

Ten63 Therapeutics

aliveseries-a
series-a
Stage

About

Ten63 Therapeutics uses machine learning-based computational chemistry and advanced search algorithms to design drug candidates that target medically validated, but traditionally undruggable, disease targets, including mutations in tumors before they occur.

Explore Ten63 Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.